Rare Qui Tam Jury False Claims Act Case: Learning Points Regarding FCA Cases Including Eli Lilly/Astellas Pharma Verdict episode artwork

EPISODE · Sep 14, 2022 · 21 MIN

Rare Qui Tam Jury False Claims Act Case: Learning Points Regarding FCA Cases Including Eli Lilly/Astellas Pharma Verdict

from Stark Integrity · host Bob Wade

Send us Fan MailJury trials under the False Claims Act (FCA) can produce very wild outcomes. In this episode, Captain Integrity Bob Wade breaks down what went down in the recent Eli Lilly/Astellas Pharma case. Hear why jury trials under the FCA are extremely rare, there are large jury verdicts, an effective compliance program can reduce or eliminate the risk of going to court, how big a return the government can receive, and how a mistake could be considered fraud. Learn more at CaptainIntegrity.com

Episode metadata supplied by the publisher feed · Published Sep 14, 2022

Embed this episode

NOW PLAYING

Rare Qui Tam Jury False Claims Act Case: Learning Points Regarding FCA Cases Including Eli Lilly/Astellas Pharma Verdict

0:00 21:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stark Integrity?

This episode is 21 minutes long.

When was this Stark Integrity episode published?

This episode was published on September 14, 2022.

Can I download this Stark Integrity episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!